NIMI
EW icon

Natixis Investment Managers International’s Edwards Lifesciences EW Stock Holding History

Natixis Investment Managers International’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$1.44M Sell
19,426
-1,050
-5% -$73.5K 0.11% 62
2024
Q3 		$1.35M Buy
20,476
+11,260
+122% +$818K 0.1% 62
2024
Q2 		$851K Sell
9,216
-350
-4% -$31K 0.06% 73
2024
Q1 		$914K Sell
9,566
-422
-4% -$35.4K 0.06% 74
2023
Q4 		$762K Sell
9,988
-48
-0.5% -$3.34K 0.05% 87
2023
Q3 		$695K Sell
10,036
-278
-3% -$22.3K 0.05% 84
2023
Q2 		$973K Buy
10,314
+336
+3% +$29.2K 0.07% 76
2023
Q1 		$825K Sell
9,978
-642
-6% -$50.5K 0.06% 82
2022
Q4 		$792K Hold
10,620
– – 0.06% 86
2022
Q3 		$877K Sell
10,620
-15,034
-59% -$1.45M 0.07% 75
2022
Q2 		$2.44M Buy
25,654
+17,767
+225% +$1.84M 0.05% 109
2022
Q1 		$928K Buy
+7,887
New +$885K 0.02% 227
2018
Q4 		– Sell
-27,708
Closed -$1.61M – 211
2018
Q3 		$1.61M Buy
27,708
+3,636
+15% +$178K 0.08% 248
2018
Q2 		$1.17M Buy
+24,072
New +$1.12M 0.06% 231
2017
Q4 		– Sell
-13,131
Closed -$478K – 235
2017
Q3 		$478K Buy
+13,131
New +$501K 0.04% 269
2016
Q4 		– Sell
-56,166
Closed -$2.26M – 432
2016
Q3 		$2.26M Buy
56,166
+564
+1% +$21.2K 0.23% 67
2016
Q2 		$1.85M Sell
55,602
-24,378
-30% -$834K 0.2% 69
2016
Q1 		$2.35M Buy
79,980
+45,918
+135% +$1.27M 0.28% 58
2015
Q4 		$897K Sell
34,062
-34,002
-50% -$883K 0.12% 102
2015
Q3 		$1.61M Buy
68,064
+2,040
+3% +$49.2K 0.22% 75
2015
Q2 		$1.57M Buy
66,024
+8,346
+14% +$188K 0.19% 85
2015
Q1 		$1.37M Buy
57,678
+50,076
+659% +$1.12M 0.17% 84
2014
Q4 		$161K Buy
+7,602
New +$153K 0.02% 285

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Natixis Investment Managers International's EW Position: Q4 2024 in Review

Natixis Investment Managers International reduced its Edwards Lifesciences (EW) stake by 5.1% in Q4 2024, selling an estimated $73.5K and leaving 19,426 shares worth $1.44M. The position accounts for 0.11% of the portfolio, ranked #62.

Natixis Investment Managers International first reported a position in EW in Q4 2014 and has held it in 23 quarters since. The position peaked at $2.44M in Q2 2022. 1,227 funds tracked by Wall St. Rank hold EW as of Q4 2024.

  • Natixis Investment Managers International held 19,426 shares of Edwards Lifesciences worth $1.44M as of Q4 2024.
  • Natixis Investment Managers International sold 1,050 Edwards Lifesciences shares in Q4 2024, an estimated $73.5K.
  • Edwards Lifesciences made up 0.11% of Natixis Investment Managers International's portfolio in Q4 2024, its #62 holding.
  • Natixis Investment Managers International first reported a position in Edwards Lifesciences in Q4 2014 and has held it in 23 quarters since.
  • Natixis Investment Managers International's Edwards Lifesciences position peaked at $2.44M in Q2 2022.
  • 1,227 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2024.

Based on Natixis Investment Managers International's 13F filing for Q4 2024, filed 13 Feb 2025.